These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3044701)

  • 1. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals.
    Hayes AA; Rose AH; Musk AW; Robinson BW
    Chest; 1988 Sep; 94(3):521-5. PubMed ID: 3044701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor.
    Hayes AA; Venaille TJ; Rose AH; Musk AW; Robinson BW
    Exp Lung Res; 1990; 16(2):121-30. PubMed ID: 2184026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolitis of pulmonary asbestosis. Bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals.
    Robinson BW; Rose AH; James A; Whitaker D; Musk AW
    Chest; 1986 Sep; 90(3):396-402. PubMed ID: 3017641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
    Garcia JG; Griffith DE; Cohen AB; Callahan KS
    Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.
    Schoenberger CI; Hunninghake GW; Kawanami O; Ferrans VJ; Crystal RG
    Thorax; 1982 Nov; 37(11):803-9. PubMed ID: 7163997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure.
    Broser M; Zhang Y; Aston C; Harkin T; Rom WN
    Int Arch Occup Environ Health; 1996; 68(2):109-14. PubMed ID: 8720280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
    Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
    Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos.
    Rom WN; Travis WD
    Chest; 1992 Mar; 101(3):779-86. PubMed ID: 1541147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased alveolar plasminogen activator in early asbestosis.
    Cantin A; Allard C; Bégin R
    Am Rev Respir Dis; 1989 Mar; 139(3):604-9. PubMed ID: 2923358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.
    Rola-Pleszczynski M; Gouin S; Bégin R
    Inflammation; 1984 Mar; 8(1):53-62. PubMed ID: 6715031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis.
    Xaubet A; Rodriguez-Roisín R; Bombí JA; Marín A; Roca J; Agustí-Vidal A
    Am Rev Respir Dis; 1986 May; 133(5):848-54. PubMed ID: 3706896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macrophages in vitro in asbestosis.
    Rom WN; Harkin T
    Environ Res; 1991 Aug; 55(2):145-56. PubMed ID: 1651223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease.
    Schwartz DA; Galvin JR; Merchant RK; Dayton CS; Burmeister LF; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):400-5. PubMed ID: 1736749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage and clearance of 99m-Tc-DTPA in asbestos workers without evidence of asbestosis.
    Gellert AR; Langford JA; Uthayakumar S; Rudd RM
    Br J Dis Chest; 1985 Jul; 79(3):251-7. PubMed ID: 3893510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta.
    Mutsaers SE; Harrison NK; McAnulty RJ; Liao JY; Laurent GJ; Musk AW
    J Pathol; 1998 Jun; 185(2):199-203. PubMed ID: 9713348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophil chemotactic factor in lung injury produced by immune complexes].
    Tanoue M
    Arerugi; 1989 Nov; 38(11):1209-16. PubMed ID: 2697200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vitro exposure to nitrogen dioxide on human alveolar macrophage release of neutrophil chemotactic factor and interleukin-1.
    Pinkston P; Smeglin A; Roberts NJ; Gibb FR; Morrow PE; Utell MJ
    Environ Res; 1988 Oct; 47(1):48-58. PubMed ID: 3049064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannin-mediated secretion of a neutrophil chemotactic factor from alveolar macrophages. Potential contribution to the acute pulmonary inflammatory reaction associated with byssinosis.
    Rohrbach MS; Kreofsky T; Rolstad RA; Russell JA
    Am Rev Respir Dis; 1989 Jan; 139(1):39-45. PubMed ID: 2492174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure].
    Tokuyama T; Yoneda T; Tamura M; Tsukaguchi K; Yoshikawa M; Tou R; Narita N; Kasuga H; Miyazaki R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):193-8. PubMed ID: 8515598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variety of neutrophil chemotactic factors in the respiratory tracts in patients with respiratory diseases].
    Hayashi H; Ozaki T; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):580-6. PubMed ID: 2214401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.